Tuesday, February 4, 2014

Seeking Alpha: Accuray Now Solidly On The Right Path

After a few quarters of "are they or aren't they?" uncertainty about Accuray's (ARAY) turnaround, I think this quarter was a significant step forward for the company. Product revenue and orders have both recovered to pre-merger levels and attitudes regarding the systems appear to have turned solidly to the positive. Valuation is becoming a trickier issue now and although the shares are not all that cheap anymore from a cash flow standpoint, the shares could still do well by the looser standards of med-tech investors.

Please read more here:
Accuray Now Solidly On The Right Path

No comments: